Evidence map›Paper›PMID 30112624›Full record

ArticleJournal of molecular neuroscience : MN2018

The Use of Multi-parametric Biomarker Profiles May Increase the Accuracy of ASD Prediction.

Wail M Hassan, Laila Al-Ayadhi, Geir Bjørklund, Altaf Alabdali, Salvatore Chirumbolo, Afaf El-Ansary

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Oxidative Stress in Autism Spectrum Disorder.Molecular neurobiology · 2020
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 5 countries.

Wail M HassanDepartment of Biomedical Sciences, College of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
Laila Al-AyadhiAutism Research and Treatment Center, King Saud University, Riyadh, Saudi Arabia.
Geir BjørklundCouncil for Nutritional and Environmental Medicine, Toften 24, 8610, Mo i Rana, Norway. bjorklund@conem.org.ORCID http://orcid.org/0000-0003-2632-3935
Altaf AlabdaliBiochemistry Department, Science College, King Saud University, Riyadh, Saudi Arabia.
Salvatore ChirumboloDepartment of Neurological and Movement Sciences, University of Verona, Verona, Italy.
Afaf El-AnsaryAutism Research and Treatment Center, King Saud University, Riyadh, Saudi Arabia.
King Saud University · SAThe Research Council of Norway · NOUniversity of Verona · ITUniversity of Wisconsin–Milwaukee · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effective biomarkers are urgently needed to facilitate early diagnosis of autism spectrum disorder (ASD), permitting early intervention, and consequently improving prognosis. In this study, we evaluate the usefulness of nine biomarkers and their association (combination) in predicting ASD onset and development. Data were analyzed using multiple independent mathematical and statistical approaches to verify the suitability of obtained results as predictive parameters. All biomarkers tested appeared useful in predicting ASD, particularly vitamin E, glutathione-S-transferase, and dopamine. Combining biomarkers into profiles improved the accuracy of ASD prediction but still failed to distinguish between participants with severe versus mild or moderate ASD. Library-based identification was effective in predicting the occurrence of disease. Due to the small sample size and wide participant age variation in this study, we conclude that the use of multi-parametric biomarker profiles directly related to autism phenotype may help predict the disease occurrence more accurately, but studies using larger, more age-homogeneous populations are needed to corroborate our findings.

Indexed as

AlgorithmsAutism Spectrum DisorderBiomarkersCase-Control StudiesChildChild, PreschoolGlutathioneHumansMaleMetals, HeavyNeurotransmitter AgentsVitamin EBiomarkersGlutathioneMetals, HeavyNeurotransmitter AgentsVitamin EAntioxidantsAutismBiomarkersHeavy metalsHierarchical clusteringNeurotransmitters

Identifiers

PMID30112624
OpenAlexW2886849137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.